Stop by booth 4369B at McCormick Place from November 29 to December 3 to discuss your AI projects and imaging data needs.
Book an in-person meeting with our co-founder on November 9 to talk about your real-world data requirements.
The study published in npj Precision Oncology validates an AI model predicting germline BRCA1/2 status from WSIs.
Come and meet our team at stand S59, Messe Basel, Switzerland, from October 6–8 to discuss your real-world data needs.
The new visual identity reflects Aigora’s evolution into an end-to-end real-world data partner for life sciences and medtech.
The KIVI research project aims to help surgeons distinguish healthy from diseased tissue directly in the operating room.
Performance of AI models for MSI detection on external validation cohorts published in Laboratory Investigation.
The agreement covers the provision of multimodal data and biospecimens for research and development across indications.
Under a master data services agreement, Aigora will provide multimodal data to support AI and product development.
De-identification best practices published in the Journal of Imaging Informatics in Medicine with co-authorship from Aigora.
The partnership aims to shorten Owkin’s time to data access and accelerate its research and development efforts.
A reader study co-authored by Aigora’s founders examines how AI support affects physicians’ melanoma diagnosis.
Clinical trial results for an AI tool trained on Aigora image data were published in the British Journal of Dermatology.
The companies are working together to make real-world data more accessible for pharmaceutical research.